NABI /DE/
424B3, 1996-11-05
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NORTEK INC, 10-Q, 1996-11-05
Next: TRANSAMERICA OCCIDENTALS SEPARATE ACCOUNT FUND C, 485BPOS, 1996-11-05



<PAGE>
 
PROSPECTUS SUPPLEMENT
To Prospectus Dated May 3, 1996,                Filed Pursuant to Rule 424(b)(3)
As Supplemented to Date                         Registration No. 333-2253





                                  $80,500,000   
                               
                                      NABI

                6 1/2% Convertible Subordinated Notes due 2003
                                      and
              Shares of Common Stock, Par Value, $.10 Per Share,
                       Issuable Upon Conversion Thereof

     This Prospectus Supplement (the "Supplement") relates to the resale by 
Lehman Brothers Inc. ("Lehman") of up to $700,000 aggregate principal amount of 
6 1/2% Convertible Subordinated Notes due 2003 (the "Notes") of NABI, a Delaware
corporation (the "Company"), originally issued in private placements consummated
on February 7 and March 6, 1996 (the "Debt Offering") pursuant to NABI's 
Registration Statement on Form S-3 (No. 333-2253) (the "Registration 
Statement"). This Supplement should be read in conjunction with the Prospectus 
dated May 3, 1996, as supplemented to date (the "Prospectus"), to be delivered 
with this Supplement. All capitalized terms used but not defined in this 
Supplement shall have the meanings given them in the Prospectus.

     Based on information provided to the Company, the aggregate principal 
amount of the Notes that are currently beneficially owned by Lehman is $700,000,
all of which may be sold at this time pursuant to the Prospectus as supplemented
hereby. Additional information concerning the Selling Securityholders (including
Lehman) may be set forth from time to time in additional supplements to the
Prospectus. The total outstanding aggregate principal amount of the Notes is
$80,500,000.

     The closing price of the Company's Common Stock as reported on The Nasdaq 
National Market on November 1, 1996 was $8.625 per share.

     The Notes will be subordinated to all existing and future Senior 
Indebtedness of the Company. At August 23, 1996, Senior Indebtedness was 
approximately $6,300,000. The Indenture contains no limitations on the 
incurrence of additional indebtedness or other liabilities by the Company.

     The Notes are neither listed on a national securities exchange nor quoted 
on an automated quotation system. However, the Notes are eligible for trading in
the Private Offerings, Resales and Trading through Automated Linkages ("PORTAL")
Market. Notes sold pursuant to the Registration Statement will no longer be 
eligible for trading in the PORTAL Market.

          The date of this Prospectus Supplement is November 4, 1996.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission